Discovery Labs Announces Changes to Board of Directors and Appoints a New...
Warrington, PA - January 04, 2013 – Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced...
View ArticleDiscovery Labs Initiates Launch of AFECTAIR®
Discovery Labs Initiates Launch of AFECTAIR® CP Wire
View ArticleDiscovery Labs Announces Changes to Board of Directors and Appoints a New...
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer CP Wire
View ArticleDiscovery Laboratories: Innovative Financing Is A Catalyst To Buy The Stock
Discovery Laboratories: Innovative Financing Is A Catalyst To Buy The Stock Seeking Alpha
View ArticleDiscovery Labs Earnings: An Early Look
Discovery Labs Earnings: An Early Look Motley Fool
View ArticleDiscovery Laboratories: The Surfaxin Launch And Beyond
Discovery Laboratories: The Surfaxin Launch And Beyond Seeking Alpha
View ArticleDiscovery Labs Announces Newly-Released Surfaxin (lucinactant) Publications
Discovery Labs Announces Newly-Released Surfaxin (lucinactant) Publications Yahoo/PR Newswire
View Article3 Biotechs With Upcoming Product Launches
3 Biotechs With Upcoming Product Launches Seeking Alpha
View ArticleDiscovery Labs receives FDA recommendatoins for Surfaxin specifications
Discovery Labs receives FDA recommendatoins for Surfaxin specifications The Fly on the Wall
View ArticleDiscovery Labs Prices $14.25 Million Public Offering of Common Stock
Discovery Labs Prices $14.25 Million Public Offering of Common Stock Yahoo
View ArticleDiscovery Labs Responds to FDA Request for Clarification of Recently...
Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product SpecificationsWarrington, PA — June 10, 2013 — Discovery Laboratories, Inc....
View ArticleDiscovery Labs Responds to FDA Request for Clarification of Recently...
Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications CP Wire
View ArticleDiscovery Labs announces FDA approval of Surfaxin
Discovery Labs announces FDA approval of Surfaxin Yahoo/Fly on the Wall
View ArticleDiscovery Laboratories: What The Marketing Approval Of Surfaxin Could Mean To...
Discovery Laboratories: What The Marketing Approval Of Surfaxin Could Mean To The Stock Seeking Alpha
View ArticleWhat's Behind This Biotech's 40% Pop?
What's Behind This Biotech's 40% Pop? Motley Fool
View Article4 Biotechnology Stocks With Room To Climb
4 Biotechnology Stocks With Room To Climb Seeking Alpha
View ArticleDiscovery Labs Reports Third Quarter 2013 Financial Results
Discovery Labs Reports Third Quarter 2013 Financial Results Yahoo
View Article
